We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Application
Liraglutide is type 2 diabetes therapy and revolutionized the field of drug , Applicable to use metformin or sulfonylureas maximum tolerated dose still poorly controlled blood sugar after treatment in patients with type 2 diabetes, glucose concentration dependent manner to regulate blood sugar, protect B cells directly, increase insulin secretion and decrease a cell in inappropriate glucagon secretion, by increasing satiety and reducing caloric intake and body weight reduction, lower systolic blood pressure (SBP), earlier used better. Liraglutide peptide with metformin or a sulfonylurea drug combination has a significant effect, less adverse reaction.
The above information is edited by the Chemicalbook Hanya.
Purity :99%
Molecular Formula C172H265N43O51 Molecular Weight
Company profile
Our company, as one of the most experienced exporter in China,specializes in API
and medicine intermediates. We export large quantity to USA,Europe and many other
countries all of the world, deal to high quality and reasonable price.
Three years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
